Want to join the conversation?
$VRTX said that it expects the vast majority of the eligible patients ages 12 and older in the U.S. will initiate treatment with Orkambi by the end of this year. The company expects to deliver quarter to quarter revenue growth for Orkambi beginning in 2Q16 and continuing through the end of 2016 and into 2017.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?